Kezar Life Sciences
54 hedge funds and large institutions have $30.9M invested in Kezar Life Sciences in 2019 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 20 increasing their positions, 9 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
60% less capital invested
Capital invested by funds: $77.2M → $30.9M (-$46.3M)
Holders
54
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$295K | |
| 2 | +$293K | |
| 3 | +$265K | |
| 4 |
AIM
Alambic Investment Management
Belvedere,
California
|
+$209K |
| 5 |
Two Sigma Advisers
New York
|
+$208K |
Top Sellers
| 1 | -$4.5M | |
| 2 | -$1.16M | |
| 3 | -$534K | |
| 4 |
BCP
Berylson Capital Partners
Boston,
Massachusetts
|
-$424K |
| 5 |
PM
Prosight Management
Dallas,
Texas
|
-$264K |